Role of MicroRNA-30c in cancer progression

被引:38
作者
Han, Wenyan [1 ]
Cui, Hongwei [2 ]
Liang, Junqing [3 ]
Su, Xiulan [2 ]
机构
[1] Inner Mongolia Med Univ, Lab Affiliated Hosp 2, 1 Yingfang Rd, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Affiliated Hosp, Clin Med Res Ctr, Inner Mongolia Key Lab Med Cellular Biol, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Inner Mongolia Autonomous Reg Canc Hosp, Dept Breast Oncol, Hohhot 010050, Inner Mongolia, Peoples R China
来源
JOURNAL OF CANCER | 2020年 / 11卷 / 09期
基金
中国国家自然科学基金;
关键词
microRNAs; microRNA-30c; cancer progression; cancer treatment; cancer prognosis; TUMOR-SUPPRESSOR; LUNG-CANCER; RNA-INTERFERENCE; EXPRESSION; MIR-30C; GENES; POLYMORPHISMS; CARCINOMA; CELLS; CONTRIBUTES;
D O I
10.7150/jca.38449
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs or miRs) is a non-coding small RNA of a type of 18 similar to 24 nucleotide-regulated gene that has been discovered in recent years. It mainly degrades the target gene mRNA or inhibits its translation process through the complete or incomplete bindings with 3'UTR of target genes, followed by the regulation of individual development, apoptosis, proliferation, differentiation and other life activities through the post-transcriptional regulation. Among many miRNAs, the microRNA family, miR-30, plays diverse roles in these key process of neoplastic transformation, metastasis, and clinical outcomes in different cancer progression. As key member of miR-30, miR-30c is regulated by oncogenic transcription factors and cancer progression related genes. Recently, numerous studies have demonstrated that the aberrant expression of miR-30c was significantly associated with the majority of human cancer progression. In this review, the diverse roles of miR-30c in different cancer progression such as the cellular and molecular mechanisms, the potential applications in clinics were summarized to speculate the benefits of miR-30c over-expression in cancer treatment and prognosis.
引用
收藏
页码:2593 / 2601
页数:9
相关论文
共 63 条
  • [11] Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy response
    Fang, Chao
    Li, Xiang-Ping
    Chen, Yi-Xin
    Wu, Na-Yiyuan
    Yin, Ji-Ye
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3329 - 3340
  • [12] MicroRNA profiling in human medulloblastoma
    Ferretti, Elisabetta
    De Smaele, Enrico
    Po, Agnese
    Di Marcotullio, Lucia
    Tosi, Emanuele
    Espinola, Maria Salome B.
    Di Rocco, Concezio
    Riccardi, Riccardo
    Giangaspero, Felice
    Farcomeni, Alessio
    Nofroni, Italo
    Laneve, Pietro
    Gioia, Ubaldo
    Caffarelli, Elisa
    Bozzoni, Irene
    Screpanti, Isabella
    Gulino, Alberto
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 568 - 577
  • [13] miR-30c-1*promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1
    Gong, Jiuyu
    Liu, Rongrong
    Zhuang, Ran
    Zhang, Yun
    Fang, Liang
    Xu, Zhuwei
    Jin, Liang
    Wang, Tao
    Song, Chaojun
    Yang, Kun
    Wei, Yuying
    Yang, Angang
    Jin, Boquan
    Chen, Lihua
    [J]. CANCER SCIENCE, 2012, 103 (04) : 645 - 652
  • [14] miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer
    Gu Yan-fei
    Zhang Hui
    Su Dan
    Mo Min-li
    Song Pan
    Zhang Fang
    Zhang Shu-cai
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (23) : 4435 - 4439
  • [15] Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer
    Guo, Tingting
    Li, Junyao
    Zhang, Lin
    Hou, Wei
    Wang, Rongrong
    Zhang, Jie
    Gao, Peng
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 31 - 48
  • [16] Expression of miR-30c and BCL-9 in gastric carcinoma tissues and their function in the development of gastric cancer
    Han, Wenyan
    Mu, Yongping
    Zhang, Zhihui
    Su, Xiulan
    [J]. ONCOLOGY LETTERS, 2018, 16 (02) : 2416 - 2426
  • [17] MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases
    Heinzelmann, Joana
    Unrein, Andre
    Wickmann, Ulrike
    Baumgart, Sophie
    Stapf, Marcus
    Szendroi, Attila
    Grimm, Marc-Oliver
    Gajda, Mieczyslaw R.
    Wunderlich, Heiko
    Junker, Kerstin
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 1046 - 1054
  • [18] Genetic Polymorphisms in the Precursor MicroRNA Flanking Region and Non-Small Cell Lung Cancer Survival
    Hu, Zhibin
    Shu, Yongqian
    Chen, Yijiang
    Chen, Jiaping
    Dong, Jing
    Liu, Yao
    Pan, Shiyang
    Xu, Lin
    Xu, Jing
    Wang, Yi
    Dai, Juncheng
    Ma, Hongxia
    Jin, Guangfu
    Shen, Hongbing
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (05) : 641 - 648
  • [19] A guide to microRNA-mediated gene silencing
    Huberdeau, Miguel Quevillon
    Simard, Martin J.
    [J]. FEBS JOURNAL, 2019, 286 (04) : 642 - 652
  • [20] A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA
    Hutvágner, G
    McLachlan, J
    Pasquinelli, AE
    Bálint, É
    Tuschl, T
    Zamore, PD
    [J]. SCIENCE, 2001, 293 (5531) : 834 - 838